Compile Data Set for Download or QSAR
maximum 50k data
Found 24 Enz. Inhib. hit(s) with all data for entry = 10879
TargetProtein cereblon(Homo sapiens (Human))
Monte Rosa Therapeutics

WIPO
LigandPNGBDBM576132(WO2021069705, Compound 2)
Affinity DataIC50:  254nMAssay Description:Compound activity was monitored in a fluorescence polarization (FP) homogeneous assay using 1 -[5-({2-[2-(2-{[2-(2,6-dioxopiperidin-3-yl)-1 ,3-dioxo-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetProtein cereblon(Homo sapiens (Human))
Monte Rosa Therapeutics

WIPO
LigandPNGBDBM576137(WO2021069705, Compound 7)
Affinity DataIC50:  324nMAssay Description:Compound activity was monitored in a fluorescence polarization (FP) homogeneous assay using 1 -[5-({2-[2-(2-{[2-(2,6-dioxopiperidin-3-yl)-1 ,3-dioxo-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetProtein cereblon(Homo sapiens (Human))
Monte Rosa Therapeutics

WIPO
LigandPNGBDBM576135(WO2021069705, Compound 5)
Affinity DataIC50:  339nMAssay Description:Compound activity was monitored in a fluorescence polarization (FP) homogeneous assay using 1 -[5-({2-[2-(2-{[2-(2,6-dioxopiperidin-3-yl)-1 ,3-dioxo-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetProtein cereblon(Homo sapiens (Human))
Monte Rosa Therapeutics

WIPO
LigandPNGBDBM576152(WO2021069705, Compound 22)
Affinity DataIC50:  393nMAssay Description:Compound activity was monitored in a fluorescence polarization (FP) homogeneous assay using 1 -[5-({2-[2-(2-{[2-(2,6-dioxopiperidin-3-yl)-1 ,3-dioxo-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetProtein cereblon(Homo sapiens (Human))
Monte Rosa Therapeutics

WIPO
LigandPNGBDBM576133(WO2021069705, Compound 3)
Affinity DataIC50:  400nMAssay Description:Compound activity was monitored in a fluorescence polarization (FP) homogeneous assay using 1 -[5-({2-[2-(2-{[2-(2,6-dioxopiperidin-3-yl)-1 ,3-dioxo-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetProtein cereblon(Homo sapiens (Human))
Monte Rosa Therapeutics

WIPO
LigandPNGBDBM576153(WO2021069705, Compound 23)
Affinity DataIC50:  464nMAssay Description:Compound activity was monitored in a fluorescence polarization (FP) homogeneous assay using 1 -[5-({2-[2-(2-{[2-(2,6-dioxopiperidin-3-yl)-1 ,3-dioxo-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetProtein cereblon(Homo sapiens (Human))
Monte Rosa Therapeutics

WIPO
LigandPNGBDBM576136(WO2021069705, Compound 6)
Affinity DataIC50:  467nMAssay Description:Compound activity was monitored in a fluorescence polarization (FP) homogeneous assay using 1 -[5-({2-[2-(2-{[2-(2,6-dioxopiperidin-3-yl)-1 ,3-dioxo-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetProtein cereblon(Homo sapiens (Human))
Monte Rosa Therapeutics

WIPO
LigandPNGBDBM576138(WO2021069705, Compound 8)
Affinity DataIC50:  468nMAssay Description:Compound activity was monitored in a fluorescence polarization (FP) homogeneous assay using 1 -[5-({2-[2-(2-{[2-(2,6-dioxopiperidin-3-yl)-1 ,3-dioxo-...More data for this Ligand-Target Pair
In DepthDetails PubMed
TargetProtein cereblon(Homo sapiens (Human))
Monte Rosa Therapeutics

WIPO
LigandPNGBDBM576134(WO2021069705, Compound 4)
Affinity DataIC50:  483nMAssay Description:Compound activity was monitored in a fluorescence polarization (FP) homogeneous assay using 1 -[5-({2-[2-(2-{[2-(2,6-dioxopiperidin-3-yl)-1 ,3-dioxo-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetProtein cereblon(Homo sapiens (Human))
Monte Rosa Therapeutics

WIPO
LigandPNGBDBM576147(WO2021069705, Compound 17)
Affinity DataIC50:  514nMAssay Description:Compound activity was monitored in a fluorescence polarization (FP) homogeneous assay using 1 -[5-({2-[2-(2-{[2-(2,6-dioxopiperidin-3-yl)-1 ,3-dioxo-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetProtein cereblon(Homo sapiens (Human))
Monte Rosa Therapeutics

WIPO
LigandPNGBDBM576150(WO2021069705, Compound 20)
Affinity DataIC50:  550nMAssay Description:Compound activity was monitored in a fluorescence polarization (FP) homogeneous assay using 1 -[5-({2-[2-(2-{[2-(2,6-dioxopiperidin-3-yl)-1 ,3-dioxo-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetProtein cereblon(Homo sapiens (Human))
Monte Rosa Therapeutics

WIPO
LigandPNGBDBM576148(WO2021069705, Compound 18)
Affinity DataIC50:  552nMAssay Description:Compound activity was monitored in a fluorescence polarization (FP) homogeneous assay using 1 -[5-({2-[2-(2-{[2-(2,6-dioxopiperidin-3-yl)-1 ,3-dioxo-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetProtein cereblon(Homo sapiens (Human))
Monte Rosa Therapeutics

WIPO
LigandPNGBDBM576149(WO2021069705, Compound 19)
Affinity DataIC50:  576nMAssay Description:Compound activity was monitored in a fluorescence polarization (FP) homogeneous assay using 1 -[5-({2-[2-(2-{[2-(2,6-dioxopiperidin-3-yl)-1 ,3-dioxo-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetProtein cereblon(Homo sapiens (Human))
Monte Rosa Therapeutics

WIPO
LigandPNGBDBM576139(WO2021069705, Compound 9)
Affinity DataIC50:  617nMAssay Description:Compound activity was monitored in a fluorescence polarization (FP) homogeneous assay using 1 -[5-({2-[2-(2-{[2-(2,6-dioxopiperidin-3-yl)-1 ,3-dioxo-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetProtein cereblon(Homo sapiens (Human))
Monte Rosa Therapeutics

WIPO
LigandPNGBDBM576151(WO2021069705, Compound 21)
Affinity DataIC50:  622nMAssay Description:Compound activity was monitored in a fluorescence polarization (FP) homogeneous assay using 1 -[5-({2-[2-(2-{[2-(2,6-dioxopiperidin-3-yl)-1 ,3-dioxo-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetProtein cereblon(Homo sapiens (Human))
Monte Rosa Therapeutics

WIPO
LigandPNGBDBM576140(WO2021069705, Compound 10)
Affinity DataIC50:  763nMAssay Description:Compound activity was monitored in a fluorescence polarization (FP) homogeneous assay using 1 -[5-({2-[2-(2-{[2-(2,6-dioxopiperidin-3-yl)-1 ,3-dioxo-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetProtein cereblon(Homo sapiens (Human))
Monte Rosa Therapeutics

WIPO
LigandPNGBDBM576146(WO2021069705, Compound 16)
Affinity DataIC50:  817nMAssay Description:Compound activity was monitored in a fluorescence polarization (FP) homogeneous assay using 1 -[5-({2-[2-(2-{[2-(2,6-dioxopiperidin-3-yl)-1 ,3-dioxo-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetProtein cereblon(Homo sapiens (Human))
Monte Rosa Therapeutics

WIPO
LigandPNGBDBM576145(WO2021069705, Compound 15)
Affinity DataIC50:  902nMAssay Description:Compound activity was monitored in a fluorescence polarization (FP) homogeneous assay using 1 -[5-({2-[2-(2-{[2-(2,6-dioxopiperidin-3-yl)-1 ,3-dioxo-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetProtein cereblon(Homo sapiens (Human))
Monte Rosa Therapeutics

WIPO
LigandPNGBDBM576143(WO2021069705, Compound 13)
Affinity DataIC50:  944nMAssay Description:Compound activity was monitored in a fluorescence polarization (FP) homogeneous assay using 1 -[5-({2-[2-(2-{[2-(2,6-dioxopiperidin-3-yl)-1 ,3-dioxo-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetProtein cereblon(Homo sapiens (Human))
Monte Rosa Therapeutics

WIPO
LigandPNGBDBM576142(WO2021069705, Compound 12)
Affinity DataIC50:  960nMAssay Description:Compound activity was monitored in a fluorescence polarization (FP) homogeneous assay using 1 -[5-({2-[2-(2-{[2-(2,6-dioxopiperidin-3-yl)-1 ,3-dioxo-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetProtein cereblon(Homo sapiens (Human))
Monte Rosa Therapeutics

WIPO
LigandPNGBDBM576131(WO2021069705, Compound 1)
Affinity DataIC50:  1.04E+3nMAssay Description:Compound activity was monitored in a fluorescence polarization (FP) homogeneous assay using 1 -[5-({2-[2-(2-{[2-(2,6-dioxopiperidin-3-yl)-1 ,3-dioxo-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetProtein cereblon(Homo sapiens (Human))
Monte Rosa Therapeutics

WIPO
LigandPNGBDBM576141(WO2021069705, Compound 11)
Affinity DataIC50:  1.23E+3nMAssay Description:Compound activity was monitored in a fluorescence polarization (FP) homogeneous assay using 1 -[5-({2-[2-(2-{[2-(2,6-dioxopiperidin-3-yl)-1 ,3-dioxo-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetProtein cereblon(Homo sapiens (Human))
Monte Rosa Therapeutics

WIPO
LigandPNGBDBM576144(WO2021069705, Compound 14)
Affinity DataIC50:  1.42E+3nMAssay Description:Compound activity was monitored in a fluorescence polarization (FP) homogeneous assay using 1 -[5-({2-[2-(2-{[2-(2,6-dioxopiperidin-3-yl)-1 ,3-dioxo-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetProtein cereblon(Homo sapiens (Human))
Monte Rosa Therapeutics

WIPO
LigandPNGBDBM576154(WO2021069705, Compound 24)
Affinity DataIC50:  1.59E+3nMAssay Description:Compound activity was monitored in a fluorescence polarization (FP) homogeneous assay using 1 -[5-({2-[2-(2-{[2-(2,6-dioxopiperidin-3-yl)-1 ,3-dioxo-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed